Modus Therapeutics
Swedish drug development company in clinical phase focused on normalizing the lives for patients with Sickle Cell Disease. Learn more
Launch date
Employees
Market cap
€7.2m
Enterprise valuation
€6m (Public information from Sep 2024)
Share price
SEK1.725 MODTX.ST
Stockholms kommun Stockholm County (HQ)
Authorizing premium user...